Reporters learned from the Beijing Municipal Bureau of Market Supervision on the 11th that a medical appliance enterprise in Beijing had recently been investigated for selling antigen kits at a high price. The purchase and sale price difference rate of Fosun novel coronavirus (2019 nCoV) antigen detection kit (colloidal gold method) sold by the enterprise reached 273.9%, which constituted an illegal act of driving up prices, and was given a warning and fined 200000 yuan. On December 7, 2022, Chaoyang District Market Supervision Bureau received a report and filed an investigation on the high price sales of antigen kits in Chaoyang No. 1 Branch of Beijing Rehabilitation Home Medical Supplies Co., Ltd. It was found that during the period from December 1, 2022 to December 7, 2022, the parties concerned sold Fosun novel coronavirus (2019 nCoV) antigen detection kit (colloidal gold method) (specification: 25 people/box) on a platform at a price of 229 yuan/box. The purchase unit prices in different periods were 61.25 yuan/box, 67.5 yuan/box, and 75 yuan/box, respectively. The platform had different sales preferences, and the actual sales unit prices were 179 yuan/box, 216.5 yuan/box, and 229 yuan/box, respectively, The price difference rate between purchase and sales reached 273.9%, which was much higher than that of similar products in the surrounding markets during the same period. The relevant person in charge of Chaoyang District Market Supervision Bureau said that the above-mentioned acts of the parties violated the provisions of Article 14 (3) of the Price Law of the People's Republic of China and constituted an illegal act of driving up prices. According to relevant laws and regulations, the Notice of Administrative Punishment has been served on the party concerned, and the party concerned is proposed to be given an administrative punishment of warning and a fine of 200000 yuan. It is understood that on December 3, 2022, after Beijing adjusted the purchase measures of "four types of drugs", the market supervision departments of the city continued to strengthen the law enforcement and inspection of the prices of "four types of drugs", antigen detection kits and other epidemic prevention and control supplies. The Notice on Further Standardizing Market Price Behavior was issued to warn more than 2000 drug operators, including online platforms and large drug distributors, and guide enterprises to consciously regulate price behavior. The relevant person in charge of the Beijing Market Supervision Bureau said that the general public is expected to participate in the supervision, find out the clues of price violations, keep relevant bills, and timely make complaints. The market supervision department will find one case to be investigated and dealt with strictly and quickly, and will publicly expose the typical cases with bad circumstances. (Outlook New Times)